{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:05:55Z","timestamp":1789470355791,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Ministry of Health, Labour and Welfare of Japan","award":["H29-Policy-Designated-009 and H29-ICT-Genral-004"],"award-info":[{"award-number":["H29-Policy-Designated-009 and H29-ICT-Genral-004"]}]},{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["17H04141"],"award-info":[{"award-number":["17H04141"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Japan Agency for Medical Research and Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s13181-018-0669-1","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T19:18:30Z","timestamp":1529090310000},"page":"237-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Cholinergic Crisis Caused by Cholinesterase Inhibitors: a Retrospective Nationwide Database Study"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8544-2569","authenticated-orcid":false,"given":"Hiroyuki","family":"Ohbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"key":"669_CR1","doi-asserted-by":"crossref","unstructured":"Gorecki L, Korabecny J, Musilek K, Nepovimova E, Malinak D, Kucera T, et al. Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016). Expert Opin Ther Pat. 2017;27(9):971\u201385.","DOI":"10.1080\/13543776.2017.1338275"},{"issue":"1","key":"669_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/156802606775193293","volume":"6","author":"GH Lushington","year":"2006","unstructured":"Lushington GH, Guo JX, Hurley MM. Acetylcholinesterase: molecular modeling with the whole toolkit. Curr Top Med Chem. 2006;6(1):57\u201373.","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"669_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0163-7258(93)90066-M","volume":"58","author":"TC Marrs","year":"1993","unstructured":"Marrs TC. Organophosphate poisoning. Pharmacol Ther. 1993;58(1):51\u201366.","journal-title":"Pharmacol Ther"},{"key":"669_CR4","doi-asserted-by":"crossref","unstructured":"Korabecny J, Andrs M, Nepovimova E, Dolezal R, Babkova K, Horova A, et al. 7-Methoxytacrine-p-anisidine hybrids as novel dual binding site acetylcholinesterase inhibitors for Alzheimer\u2019s disease treatment. Molecules. 2015;20(12):22084\u2013101.","DOI":"10.3390\/molecules201219836"},{"key":"669_CR5","doi-asserted-by":"crossref","unstructured":"Nepovimova E, Korabecny J, Dolezal R, Babkova K, Ondrejicek A, Jun D, et al. Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity. J Med Chem. 2015;58(22):8985\u20139003.","DOI":"10.1021\/acs.jmedchem.5b01325"},{"key":"669_CR6","doi-asserted-by":"crossref","unstructured":"Alonso D, Dorronsoro I, Rubio L, Mu\u00f1oz P, Garc\u00eda-Palomero E, del Monte M, et al. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE. Bioorg Med Chem. 2005;13(24):6588\u201397.","DOI":"10.1016\/j.bmc.2005.09.029"},{"issue":"17","key":"669_CR7","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.2174\/092986710791111198","volume":"17","author":"M Komloova","year":"2010","unstructured":"Komloova M, Musilek K, Dolezal M, Gunn-Moore F, Kuca K. Structure-activity relationship of quaternary acetylcholinesterase inhibitors\u2014outlook for early myasthenia gravis treatment. Curr Med Chem. 2010;17(17):1810\u201324.","journal-title":"Curr Med Chem"},{"issue":"6","key":"669_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2220\/biomedres.28.287","volume":"28","author":"K Sugaya","year":"2007","unstructured":"Sugaya K, Onaga T, Nishijima S, et al. Relationship between serum cholinesterase level and urinary bladder activity in patients with or without overactive bladder and\/or neurogenic bladder. Biomed Res. 2007;28(6):287\u201394.","journal-title":"Biomed Res"},{"key":"669_CR9","doi-asserted-by":"crossref","unstructured":"Sugimoto K, Akiyama T, Shimizu N, Matsumura N, Hashimoto M, Minami T, et al. Acotiamide hydrochloride hydrate added to combination treatment with an alpha-blocker and a cholinergic drug improved the QOL of women with acute urinary retention: case series. Res Rep Urol. 2017;9:141\u20133.","DOI":"10.2147\/RRU.S133952"},{"issue":"8","key":"669_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/01.pec.0000173353.76142.81","volume":"21","author":"KA Hetherington","year":"2005","unstructured":"Hetherington KA, Losek JD. Myasthenia gravis: myasthenia vs. cholinergic crisis. Pediatr Emerg Care. 2005;21(8):546\u20138. quiz 549\u201351","journal-title":"Pediatr Emerg Care"},{"issue":"2","key":"669_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s13181-012-0214-6","volume":"8","author":"MJ Abedin","year":"2012","unstructured":"Abedin MJ, Sayeed AA, Basher A, Maude RJ, Hoque G, Faiz MA. Open-label randomized clinical trial of atropine bolus injection versus incremental boluses plus infusion for organophosphate poisoning in Bangladesh. J Med Toxicol. 2012;8(2):108\u201317.","journal-title":"J Med Toxicol"},{"issue":"2","key":"669_CR12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1742-1241.1994.tb09770.x","volume":"48","author":"A Hameed","year":"1994","unstructured":"Hameed A, Charles TJ. Cholinergic crisis following treatment of postoperative urinary retention with distigmine bromide. Br J Clin Pract. 1994;48(2):103\u20134.","journal-title":"Br J Clin Pract"},{"issue":"1","key":"669_CR13","first-page":"21","volume":"48","author":"S Yamanaka","year":"2002","unstructured":"Yamanaka S, Fujita I, Murota T, Kawakita M, Matsuda T. Cholinergic crisis following administration of distigmine bromide: a case report. Hinyokika Kiyo. 2002;48(1):21\u20133. Japanese","journal-title":"Hinyokika Kiyo"},{"issue":"8","key":"669_CR14","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.2169\/naika.87.1566","volume":"87","author":"R Tadara","year":"1998","unstructured":"Tadara R, Kobayashi M, Nakamura N, et al. Patients confined in bed for an extended period and developing cholinergic crisis following administration of distigmine bromide: report of 3 cases. Nihon Naika Gakkai Zasshi. 1998;87(8):1566\u20137. Japanese","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"669_CR15","unstructured":"Kobayashi K, Sekiguchi H, Sato N, Hirose Y. Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment. Chudoku Kenkyu. 2016;29(1):26\u20139. Japanese"},{"key":"669_CR16","unstructured":"Takahashi M, Ubukata S, Sato E, Shoji M, Morikawa N, Watanabe H, et al. Acute respiratory failure associated with cholinergic crisis: report of five cases and review of the literature. Nihon Kokyuki Gakkai Zasshi. 2011;49(12):877\u201384. Japanese"},{"key":"669_CR17","doi-asserted-by":"crossref","unstructured":"Huang X, Liu WB, Men LN, Feng HY, Li Y, Luo CM, et al. Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years. Neurol Sci. 2013;34(6):911\u20137.","DOI":"10.1007\/s10072-012-1157-z"},{"key":"669_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","volume":"27","author":"H Yamana","year":"2017","unstructured":"Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476\u201382.","journal-title":"J Epidemiol"},{"key":"669_CR19","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:56\u201361."},{"issue":"4","key":"669_CR20","doi-asserted-by":"publisher","first-page":"e002736","DOI":"10.1136\/bmjopen-2013-002736","volume":"3","author":"K Shigematsu","year":"2013","unstructured":"Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is sufficient to predict stroke outcome\u2014reintroduction of Japan Coma Scale: a cohort study. BMJ Open. 2013;3(4):e002736.","journal-title":"BMJ Open"},{"key":"669_CR21","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation presented at: the World Health Organization; June 3\u20135, 1997; Geneva, Switzerland. Publication WHO\/NUT\/NCD\/98.1."},{"issue":"2","key":"669_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/09638288809164105","volume":"10","author":"DT Wade","year":"1988","unstructured":"Wade DT, Collin C. The Barthel ADL index: a standard measure of physical disability? Int Disabil Stud. 1988;10(2):64\u20137.","journal-title":"Int Disabil Stud"},{"issue":"1","key":"669_CR23","first-page":"3","volume":"54","author":"A Ohta","year":"2007","unstructured":"Ohta A, Nagai M, Nishina M, Shibazaki S, Ishijima H, Izumida M. Age at the onset of intractable disease: based on a clinical database for patients receiving financial aid for treatment. Nihon Koshu Eisei Zasshi. 2007;54(1):3\u201314. Japanese","journal-title":"Nihon Koshu Eisei Zasshi"},{"key":"669_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000065639","volume":"21","author":"B Kalb","year":"2002","unstructured":"Kalb B, Matell G, Pirskanen R, Lambe M. Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden. Neuroepidemiology. 2002;21:221\u20135.","journal-title":"Neuroepidemiology"},{"issue":"3","key":"669_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1378\/chest.98.3.631","volume":"98","author":"TC Tsao","year":"1990","unstructured":"Tsao TC, Juang YC, Lan RS, et al. Respiratory failure of acute organophosphate and carbamate poisoning. Chest. 1990;98(3):631\u20136.","journal-title":"Chest"},{"key":"669_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","volume":"48\u201349","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B. Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun. 2014;48\u201349:143\u20138.","journal-title":"J Autoimmun"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-018-0669-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-018-0669-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-018-0669-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T06:16:58Z","timestamp":1693721818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-018-0669-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1007\/s13181-018-0669-1","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]},"assertion":[{"value":"7 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}